Bristol Myers Squibb Partners With Microsoft For Lung-Cancer Detection

Bristol Myers Squibb on Tuesday announced a collaboration with Microsoft to accelerate early detection of lung cancer using Microsoft's AI-powered radiology platform and FDA-cleared radiology algorithms. The partnership will deploy the AI tools into clinical radiology workflows to enhance screening and diagnostic sensitivity, potentially shortening time-to-detection and informing treatment decisions for at-risk patients.